B1MR34

BioMarin Pharmaceutical Inc.

BR Healthcare Biotechnology

52-week price+19.6%

Latest week: 18 Sep 2026
Weekly close: 168.80 BRL
Fair value: 185.40 BRL
Next-week expectancy: Negative 35.51%

Seven-day news and sentiment · 14–20 September 2026

Recent company news is balanced

Stored company coverage from the last seven days has not established a clear directional balance.

Open news and sentiment summary →

Headlines · 7 days3

Publishers2

Headline balance0+ · 0−3 neutral

30-day weighted score52/100Neutral · Held steady

18 Sep, 18:02
finance.yahoo.com · Main companyBioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone
16 Sep, 17:01
finance.yahoo.com · Main companyBioMarin Stops Voxzogo Development for Noonan Syndrome
14 Sep, 14:05
PR Newswire · Main companyBioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

Completed daily analysis

Preparing this listing’s daily history

The live session price remains available above. Completed OHLCV history is fetched on demand for listings that are opened, so the rest of the market does not need a daily collection pass.

Daily history update queued A background task is preparing missing or newer completed sessions. Refresh this page shortly.

B1MR34

Delayed price and five-minute path

Recent company news is balanced

Preparing this listing’s daily history

Send a message

Evidence context